News, Short Squeeze, Breakout and More Instantly...
NEW YORK, NY / ACCESSWIRE / October 20, 2023 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of CM Life Sciences III Inc. ("CM Life Sciences"), which was acquired by EQRx, Inc. ("EQRx") (NASDAQ:EQRX) on August 5, 2021. Investors who purchased CM...
Business combination with CM Life Sciences III results in approximately $1.3 billion in cash proceeds Combined company to trade on Nasdaq Global Market under ticker “EQRX” NEW YORK and CAMBRIDGE, Mass., Dec. 17, 2021 (GLOBE NEWSWIRE) -- CM Life Sciences III (Nasdaq...